Pegasus Biologics Inc. Enables World’s First Biosurgical Mesh for Arthroscopic Rotator Cuff Repair

IRVINE, Calif.--(BUSINESS WIRE)--Pegasus Biologics, Inc., a developer of unique collagen scaffolds for soft tissue repair, announced today that its OrthADAPT® PR Bioimplant, a Class 2 medical device, has now been utilized by surgeons in a first-of-its kind rotator cuff repair procedure. Pegasus’ biologically based surgical mesh is specifically engineered for arthroscopic delivery and utilizes Pegasus’ existing OrthADAPT collagen matrix combined with a special polymer mesh for added strength and to facilitate surgical delivery.

MORE ON THIS TOPIC